Ausgabe 3/2018
Inhalt (8 Artikel)
Thyroid Hormone in the Clinic and Breast Cancer
Aleck Hercbergs, Shaker A. Mousa, Matthew Leinung, Hung-Yun Lin, Paul J. Davis
Leptin Involvement in Primary Brain and Pituitary Tumors: Therapeutic Potential, Prognostic Value, and Proposed Diagnostic Application
Christos Bikis, Theodora Tzanavari, Krystallenia I. Alexandraki, Stamatios Theocharis
Thyroid Hormone Promotes β-Catenin Activation and Cell Proliferation in Colorectal Cancer
Yee-Shin Lee, Yu-Tang Chin, Ya-Jung Shih, André Wendindondé Nana, Yi-Ru Chen, Han-Chung Wu, Yu-Chen S. H. Yang, Hung-Yun Lin, Paul J. Davis
Adiponectin Reverses the Proliferative Effects of Estradiol and IGF-1 in Human Epithelial Ovarian Cancer Cells by Downregulating the Expression of Their Receptors
Marta Hoffmann, Justyna Gogola, Anna Ptak
Combinatorial Effect of Abiraterone Acetate and NVP-BEZ235 on Prostate Tumor Progression in Rats
Bianca Facchim Gonçalves, Silvana Gisele Pegorin de Campos, Wagner José Fávaro, Joyce Zalotti Brandt, Cristiane Figueiredo Pinho, Luis Antônio Justulin, Sebastião Roberto Taboga, Wellerson Rodrigo Scarano
Fasting Blood Glucose Level in Locally Advanced Non-Small Cell Lung Cancer: a New Prognostic Factor?
Esra Korkmaz Kirakli, Ufuk Yilmaz, Hasan Yilmaz, Berna Komurcuoglu
Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis
Zhiyu Li, Qi Wu, Junlong Song, Yimin Zhang, Shan Zhu, Shengrong Sun
Type 1 IGF Receptor Localization in Paediatric Gliomas: Significant Association with WHO Grading and Clinical Outcome
Florencia Clément, Ayelen Martin, Marcela Venara, Maria de Luján Calcagno, Cecilia Mathó, Silvana Maglio, Mercedes García Lombardi, Ignacio Bergadá, Patricia A Pennisi